Patents and R&D projects, such as the development of new pharmaceuticals, are subject to substantial uncertainty in both the investment phase, which can be long and costly, as well as uncertainty about the market prospects of a commercialized product. Additionally managers possess operational flexibility allowing them to abandon projects that either become too costly to … Continue reading Valuing R&D and Patents with Real Options Analysis